Venous thromboembolic events in minimally invasive gynecologic surgery

Journal of Minimally Invasive Gynecology

Volumn 20, Issue 6, 2013, Pages 766-769

  Ramirez, Pedro T ^a   Nick, Alpa M ^a   Frumovitz, Michael ^a   Schmeler, Kathleen M ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Laparoscopy; Robotics; Thromboprophylaxis

Indexed keywords

DALTEPARIN; ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

CANCER SURGERY; COMPRESSION INSTRUMENT; DEEP VEIN THROMBOSIS; EMBOLISM PREVENTION; ENDOMETRIUM CANCER; GYNECOLOGIC CANCER; GYNECOLOGIC SURGERY; HEALTH CARE QUALITY; LUNG EMBOLISM; MINIMALLY INVASIVE SURGERY; NONHUMAN; POSTOPERATIVE COMPLICATION; PRACTICE GUIDELINE; REVIEW; VENOUS THROMBOEMBOLISM;

LAPAROSCOPY; ROBOTICS; THROMBOPROPHYLAXIS;

FEMALE; GYNECOLOGIC SURGICAL PROCEDURES; HUMANS; SURGICAL PROCEDURES, MINIMALLY INVASIVE; VENOUS THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 84886861836     PISSN: 15534650     EISSN: 15534669     Source Type: Journal    
DOI: 10.1016/j.jmig.2013.06.001     Document Type: Review

References (23)

1. Heit J.A., O'Fallon W.M., Petterson T.M., et al. Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study. Arch Intern Med 2002, 10:1245-1248.
2. Geerts W.H., Pineo G.F., Heit J.A., et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004, 126:338S-400S.
3. Schmeler K.M., Wilson G.L., Cain K., et al. Venous thromboembolism (VTE) rates following the implementation of extended duration prophylaxis for patients undergoing surgery for gynecologic malignancies. Gynecol Oncol 2013, 128:204-208.
4. Martino M.A., Borges E., Williamson E., et al. Pulmonary embolism after major abdominal surgery in gynecologic oncology. Obstet Gynecol 2006, 107:666-671.
5. Ageno W., Manfredi E., Dentali F., et al. The incidence of venous thromboembolism following gynecologic laparoscopy: a multicenter, prospective cohort study. J Thromb Haemost 2007, 5:503-506.
6. Nick A.M., Schmeler K.M., Frumovitz M.M., et al. Risk of thromboembolic disease in patients undergoing laparoscopic gynecologic surgery. Obstet Gynecol 2010, 116:956-961.
7. Ritch J.M., Kim J.H., Lewin S.N., et al. Venous thromboembolism and use of prophylaxis among women undergoing laparoscopic hysterectomy. Obstet Gynecol 2011, 117:1367-1374.
8. Sandadi S., Lee S., Walter A., et al. Incidence of venous thromboembolism after minimally invasive surgery in patients with newly diagnosed endometrial cancer. Obstet Gynecol 2012, 120:1077-1083.
9. Kumar S., Al-Wahab Z., Sarangi S., et al. Risk of postoperative venous thromboembolism after minimally invasive surgery for endometrial and cervical cancer is low: a multi-institutional study. Gynecol Oncol 2013, 130:207-212.
10. Walker J.L., Piedmonte M.R., Spirtos N.M., et al. Laparoscopy compared with laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group Study LAP2. J Clin Oncol 2009, 27:5331-5336.
11. Secin F.P., Jiborn T., Biartelli A.S., et al. Multi-institutional study of symptomatic deep venous thrombosis and pulmonary embolism in prostate cancer patients undergoing laparoscopic or robotic-assisted laparoscopic radical prostatectomy. Eur Urol 2008, 53:134-145.
12. Zhan C., Miller M.R. Excess length of stay, charges, and mortality attributable to medical injuries during hospitalization. JAMA 2003, 290:1868-1874.
13. Cain K., Schmeler K.M., Langley G., Max O., Ramirez P.T., Levenback C.F. Patient cost associated with filling a prescription for extended-duration venous thromboembolism (VTE) prophylaxis following surgery for gynecologic cancer. Gynecol Oncol 2012, 127:18-21.
14. Gould M.K., Garcia D.A., Wren S.M., et al. Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012, 141(2 suppl):e227S-e277S.
15. Lyman G.H., Khorana A.A., Kuderer N.M., et al. Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology Clinical Practice guideline update. JClin Oncol 2013, 31:2189-2204.
16. National Comprehensive Cancer Network (NCCN). Clinical practice guidelines in oncology; venous thromboembolic disease, v. 1.2010. Available at. Accessed May 2013. http://www.nccn.org.
17. ACOG Practice Bulletin No. 84: Prevention of deep vein thrombosis and pulmonary embolism. Obstet Gynecol 2007, 110:429-440.
18. Bergqvist D., Agnelli G., Cohen A.T., et al. Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. N Engl J Med 2002, 346:975-980.
19. Rasmussen M.S., Jorngensen L.N., Wille-Jorgensen P., et al. Prolonged prophylaxis with dalteparin to prevent late thromboembolic complications in patients undergoing major abdominal surgery: a multicenter randomized open-label study. J Thromb Haemost 2006, 4:2384-2390.
20. Martino M.A., Williamson E., Rajaram L., et al. Defining practice patterns in gynecologic oncology to prevent pulmonary embolism and deep venous thrombosis. Gynecol Oncol 2007, 106:439-445.
21. Geerts W.H., Bergqvist D., Pineo G.F., et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008, 133(6 suppl):381S-453S.
22. Hansen C.T., Kehlet H., Moller C., Morch L., Utzon J., Ottesen B. Timing of heparin prophylaxis and bleeding complications in hysterectomy: a nationwide prospective cohort study of 9,949 Danish women. Acta Obstet Gynecol Scand 2008, 87:1039-1047.
23. Worley M.J., Rauh-Hain A., Sandberg E.M., et al. Venous thromboembolism prophylaxis for laparoscopic surgery: a survey of members of the Society of Gynecologic Oncology. Int J Gynecol Cancer 2013, 23:208-215.